SAN DIEGO SHAREHOLDER'S RIGHTS LEGAL BLOG

Reata Pharmaceuticals, Inc. (RETA) Made Material Misstatements Regarding the Viability of its Drug Bardoxolone   A class action was filed on behalf of all persons

Talis Biomedical Corporation (TLIS) Issued a Misleading Registration Statement in Connection with its IPO    A shareholder filed a class action on behalf of all

Talkspace, Inc. (TALK) Issued a False and Misleading Proxy in Support of its Merger   A class action was filed on behalf of all holders

Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities    A shareholder filed a class action on behalf of all persons and entities

Clarivate Plc (CLVT) Made Financial Misstatements On December 27, 2021, Clarivate disclosed in a filing with the U.S. Securities and Exchange Commission that “[o]n December

Applied Therapeutics, Inc. (APLT) Holds Submission of New Drug Application for AT-007 Applied Therapeutics Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular

Meta Materials Inc. (MMAT) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or

Arrival SA (ARVL, ARVLW) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or

Embark Technology, Inc. (EMBK) Criticized as Being “More Bark than Bite”   Robbins LLP is investigating Embark Technology, Inc. (NASDAQ: EMBK) to determine whether certain